Product Information
METOPROLOL TARTRATE 50 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0195 per EA under NDC 72888021002. Its NADAC has been published 41 times since Dec 24, 2025.
FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888021002
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200981FDA Approved
10/28/2014
TE Code
AB
On Market Since
7/26/2024
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 50 MG TAB has been published 41 times since Dec 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0195 per EA |
|---|---|
| All-time high | $0.0200 (Mar 11, 2026) |
| All-time low | $0.0185 (Aug 19, 2026) |
| 52-week high | $0.0200 |
| 52-week low | $0.0185 |
| Median price | $0.0193 |
| Average price | $0.0193 |
| Largest weekly change | +5.1% (Sep 23, 2026) |
| Weeks tracked | 41 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METOPROLOL TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 50 MG TAB, manufactured by Advagen Pharma Ltd., is $0.0195 per EA (NDC 72888021002), effective Sep 30, 2026.
How has the price of METOPROLOL TARTRATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 50 MG TAB has held within roughly two percent of its current level. It has been tracked across 41 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 50 MG TAB?
Since Dec 24, 2025, the NADAC for METOPROLOL TARTRATE 50 MG TAB has ranged from a low of $0.0185 (Aug 19, 2026) to a high of $0.0200 (Mar 11, 2026), with a median of $0.0193 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 50 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL TARTRATE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL TARTRATE 50 MG TAB?
METOPROLOL TARTRATE 50 MG TAB (NDC 72888021002) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.